Coronavirus information

Visitor restrictions, information for patients and more.

View coronavirus information

FOI 0893 2020/21 Free of Charge Drugs

Freedom of Information Request: 0893 2020/21

I’ve got a Freedom of Information query that I hope you’ll be able to help me with

Question 1

Within the last 2 years, has the institution accepted or is it currently accepting any of the following drugs free of charge or for a nominal charge (eg £1):

Rizankizumab (Skyrizi) – Yes

Guselkumab (Tremfya) – No

Brodalumab (Kyntheum) – Yes

Ixekizumab (Taltz) – No

Secukinumab (Cosentyx) – out come scheme as opposed to a FOC scheme

Tildrakizumab (Ilumetri) – No

Question 2

If yes to any of the above, are you able to say how long is the free of charge drug stock typically provided for each patient? For example, is it :

First dose

First month

First 3 months

Some other period?

  • Rizankizumab (Skyrizi) – Until May 2020.
  • Brodalumab (Kyntheum) – first 3 months

Question 3

If the Institution has not accepted manufacturer provision of free of charge drug stock, are you able to say what have been the reasons for this?

Generally, no interest from the clinical specialties.

Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.